CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Aclaris Therapeutics Inc Company Snapshot
Aclaris Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aclaris Therapeutics Inc with three other companies in this sector in UNITED STATES : Gritstone Oncology Inc (2019 sales of $4.37 million of which 100% was BIOLOGICAL PRODUCTS), Immutep Ltd ($4.31 million of which 93% was Cancer Immunotherapy), and Ocular Therapeutix Inc ($4.23 million of which 100% was Biopharmaceutical Preparations).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Aclaris Therapeutics Inc
  Stock Performance Chart for Aclaris Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 4.30
(Figures in U.S. Dollars)
1 Week -0.2%   13 Weeks 74.8%  
4 Weeks 100.0%   52 Weeks 141.6%  
 
Aclaris Therapeutics Inc Key Data:
  Ticker: ACRS Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 4,227,000
(Year Ending Jan 2020).
Employees: 77
  Currency: U.S. Dollars Market Cap: 183,571,790
  Fiscal Yr Ends: December Shares Outstanding: 42,691,114
  Share Type: Common Closely Held Shares: 3,805,079
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.